Immunotherapy for Cancer: Checkpoints for Success?

Much of previous immunotherapy research had included less specific monoclonal antibodies (mAbs) and cancer vaccines; however, a new wave of clinical trials have re-focused on more specific signals and checkpoints within the cell cycle.